Whether you’re an adult living with anti-acetylcholine receptor (AChR) antibody positive generalized myasthenia gravis (gMG) or you’re a caregiver, My VYVGART Path has helpful resources to help you feel supported throughout the treatment journey.
AChR=acetylcholine receptor
See how the My VYVGART Path Patient Support Program can empower you on your VYVGART treatment journey.
Fill out this form to self-enroll in My VYVGART Path once you have been prescribed VYVGART.
This brochure contains important information about VYVGART Hytrulo for subcutaneous injection and VYVGART for intravenous (IV) infusion. Learn about data from 2 studies, self-injection with the VYVGART Hytrulo prefilled syringe, VYVGART support and resources, and much more.
Discover caregiver-specific education about VYVGART, self-care tips, and resources.
See if you could be eligible to pay as little as $0 for your co-pay through the VYVGART Co-pay Program.*
*Eligible, commercially insured patients may pay as little as $0 for VYVGART and may receive a maximum benefit of $25,000 per calendar year for their eligible out-of-pocket costs for the drug and drug administration. Persons residing in MA and RI are not eligible for financial assistance related to administration costs. Please see full Terms and Conditions.
The What’s Next Guide outlines what you can expect as you begin your journey with VYVGART, from navigating insurance to starting your first treatment cycle.
Learn about the insurance process and see how the My VYVGART Path team may assist you in accessing VYVGART.
Learn about the process of self-injection with the VYVGART Hytrulo prefilled syringe.
Learn about dosing and how to prepare for your VYVGART Hytrulo subcutaneous injection.
Information on the VYVGART for IV infusion process: before, during, and after.
Use this tool to track your symptoms regularly as it may help you and your neurologist plan your treatment cycles.
MG-ADL=Myasthenia Gravis Activities of Daily Living
This tool can help you set a gMG treatment goal and share it with your doctor.
In these 4 educational guides, learn about the different types of symptoms you may experience with gMG.
In these 4 educational guides, learn about the different types of symptoms you may experience with gMG.
In these 4 educational guides, learn about the different types of symptoms you may experience with gMG.
In these 4 educational guides, learn about the different types of symptoms you may experience with gMG.
The VYVGART Doctor Discussion Guide can be used to help you discuss with your neurologist current anti-AChR antibody positive gMG symptoms you have and how they impact your daily abilities.
This guide can help you facilitate productive conversations with family and friends, where you can define and ask for the support you might need.
Use this card to share treatment information and key contacts in the case of an emergency.
Get to know our NCMs, who will provide personalized support throughout your journey.
Find resources and information that may help you navigate coverage for VYVGART.
Learn how you can get enrolled in the patient support program, My VYVGART Path.
Do not take VYVGART if you are allergic to efgartigimod alfa or any of the ingredients in VYVGART. Do not take VYVGART HYTRULO if you are allergic to efgartigimod alfa, hyaluronidase, or any of the ingredients in VYVGART HYTRULO. VYVGART or VYVGART HYTRULO can cause serious allergic reactions and a decrease in blood pressure leading to fainting.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
An additional symptom of an allergic reaction with VYVGART HYTRULO can include hives.
These are not all the possible side effects of VYVGART or VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
VYVGART and VYVGART HYTRULO are both prescription medicines used to treat adults with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive.
It is not known if VYVGART or VYVGART HYTRULO is safe and effective in children.
Please see full Prescribing and Patient Information for VYVGART HYTRULO for subcutaneous injection and full Prescribing Information for VYVGART for IV infusion.
VYVGART Hytrulo is available as a single-dose subcutaneous injection containing: 200 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase per prefilled syringe, or 180 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase per vial. VYVGART is available as a single-dose injection for intravenous use containing 400 mg/20 mL of efgartigimod alfa-fcab per vial.
Do not take VYVGART if you are allergic to efgartigimod alfa or any of the ingredients in VYVGART. Do not take VYVGART HYTRULO if you are allergic to efgartigimod alfa, hyaluronidase, or any of the ingredients in VYVGART HYTRULO. VYVGART or VYVGART HYTRULO can cause serious allergic reactions and a decrease in blood pressure leading to fainting.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
An additional symptom of an allergic reaction with VYVGART HYTRULO can include hives.
These are not all the possible side effects of VYVGART or VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
VYVGART and VYVGART HYTRULO are both prescription medicines used to treat adults with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive.
It is not known if VYVGART or VYVGART HYTRULO is safe and effective in children.
Please see full Prescribing and Patient Information for VYVGART HYTRULO for subcutaneous injection and full Prescribing Information for VYVGART for IV infusion.
VYVGART Hytrulo is available as a single-dose subcutaneous injection containing: 200 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase per prefilled syringe, or 180 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase per vial. VYVGART is available as a single-dose injection for intravenous use containing 400 mg/20 mL of efgartigimod alfa-fcab per vial.
This site is intended for patients and caregivers.
Disclaimer | Privacy Policy | Contact Us |
VYVGART and VYVGART Hytrulo are registered trademarks of argenx.
For U.S. audiences only.
©2025 argenx
US-VYV-23-00235 V9 05/2025
Facebook
Twitter
Pinterest